What is the Return on Assets (ROA) of OSE Immunotherapeutics this year?
The Return on Assets (ROA) of OSE Immunotherapeutics is 0 undefined this year.
OSE Immunotherapeutics ROA 2024
OSE Immunotherapeutics ROA
0
OSE Immunotherapeutics Dividend yield
Ticker
OSE.PA
ISIN
FR0012127173
WKN
A14QXP
In 2024, OSE Immunotherapeutics's return on assets (ROA) was 0, a -100% increase from the -0.19 ROA in the previous year.
OSE Immunotherapeutics Aktienanalyse
What does OSE Immunotherapeutics do?
Ose Immunotherapeutics SA is a French biopharmaceutical company specializing in the development of cancer and autoimmune immunotherapies. The company was founded in 2008 and is based in Nantes, France. OSE Immunotherapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding OSE Immunotherapeutics's Return on Assets (ROA)
OSE Immunotherapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing OSE Immunotherapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider OSE Immunotherapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in OSE Immunotherapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about OSE Immunotherapeutics Stock
What was the ROA of OSE Immunotherapeutics compared to the previous year?
The ROA of OSE Immunotherapeutics has increased by -100% compared to the previous year.
What consequences do high ROA have for investors of OSE Immunotherapeutics?
A high ROA is advantageous for investors of OSE Immunotherapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in OSE Immunotherapeutics?
A low ROA can be unfavorable for investors of OSE Immunotherapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of OSE Immunotherapeutics affect the company?
An increase in ROA of OSE Immunotherapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of OSE Immunotherapeutics impact the company?
A reduction in the ROA of OSE Immunotherapeutics can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of OSE Immunotherapeutics?
Some factors that can influence the ROA of OSE Immunotherapeutics include revenue, operating costs, asset structure, and industry average.
Why is the ROA of OSE Immunotherapeutics important for investors?
The ROA of OSE Immunotherapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can OSE Immunotherapeutics take to improve ROA?
To improve ROA, OSE Immunotherapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does OSE Immunotherapeutics pay?
Over the past 12 months, OSE Immunotherapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OSE Immunotherapeutics is expected to pay a dividend of 0 EUR.
What is the dividend yield of OSE Immunotherapeutics?
The current dividend yield of OSE Immunotherapeutics is .
When does OSE Immunotherapeutics pay dividends?
OSE Immunotherapeutics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of OSE Immunotherapeutics?
OSE Immunotherapeutics paid dividends every year for the past 0 years.
What is the dividend of OSE Immunotherapeutics?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is OSE Immunotherapeutics located?
OSE Immunotherapeutics is assigned to the 'Health' sector.
Wann musste ich die Aktien von OSE Immunotherapeutics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of OSE Immunotherapeutics from 5/21/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/21/2024.
When did OSE Immunotherapeutics pay the last dividend?
The last dividend was paid out on 5/21/2024.
What was the dividend of OSE Immunotherapeutics in the year 2023?
In the year 2023, OSE Immunotherapeutics distributed 0 EUR as dividends.
In which currency does OSE Immunotherapeutics pay out the dividend?
The dividends of OSE Immunotherapeutics are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von OSE Immunotherapeutics
Our stock analysis for OSE Immunotherapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OSE Immunotherapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- OSE Immunotherapeutics Revenue
- OSE Immunotherapeutics Net Income
- OSE Immunotherapeutics P/E
- OSE Immunotherapeutics P/S
- OSE Immunotherapeutics EBIT
- OSE Immunotherapeutics Dividend
- OSE Immunotherapeutics Stocks
- OSE Immunotherapeutics Market capitalization
- OSE Immunotherapeutics Debt
- OSE Immunotherapeutics Liabilities
- OSE Immunotherapeutics Equity
- OSE Immunotherapeutics AAQS
- OSE Immunotherapeutics Employees
- OSE Immunotherapeutics ROE
- OSE Immunotherapeutics ROA
- OSE Immunotherapeutics ROCE
